D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
Insulet
PODD
$11.8B
| $2.84M | ﹤0.01% |
10,000
| – | – |
|
2527
UDR
UDR
$12.9B
| $2.84M | ﹤0.01% |
53,596
+22,209
| +71% | +$1.19M |
|
2528
KB Home
KBH
$3.5B
| $2.84M | ﹤0.01% |
72,856
+66,463
| +1,040% | +$2.76M |
|
|
ANAT
2529
CALL
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.83M | ﹤0.01% |
+15,000
| New | +$2.67M |
|
2530
PUT
Meritage Homes
MTH
$4.78B
| $2.83M | ﹤0.01% |
58,400
| – | – |
|
2531
CAE Inc. Common Shares
CAE
$8.44B
| $2.83M | ﹤0.01% |
+94,869
| New | +$2.81M |
|
2532
Shake Shack
SHAK
$2.54B
| $2.83M | ﹤0.01% |
+36,070
| New | +$3.28M |
|
2533
The Bancorp
TBBK
$2.81B
| $2.83M | ﹤0.01% |
111,023
-56,536
| -34% | -$1.34M |
|
|
TCAC
2534
DELISTED
Tuatara Capital Acquisition Corporation Class A Ordinary Shares
TCAC
| $2.82M | ﹤0.01% |
289,717
+239,717
| +479% | +$2.32M |
|
|
SEE
2535
DELISTED
Sealed Air
SEE
| $2.81M | ﹤0.01% |
51,386
-10,366
| -17% | -$602K |
|
2536
XBP Global Holdings
XBP
$40M
| $2.81M | ﹤0.01% |
+28,216
| New | +$2.79M |
|
|
LEGA
2537
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
| $2.81M | ﹤0.01% |
286,961
+225,850
| +370% | +$2.2M |
|
2538
CALL
Halliburton
HAL
$26.1B
| $2.81M | ﹤0.01% |
130,000
-21,800
| -14% | -$447K |
|
2539
CALL
J.M. Smucker
SJM
$13.5B
| $2.81M | ﹤0.01% |
+23,400
| New | +$2.97M |
|
|
EPAY
2540
DELISTED
Bottomline Technologies Inc
EPAY
| $2.81M | ﹤0.01% |
71,409
-168,015
| -70% | -$6.77M |
|
2541
PUT
Paylocity
PCTY
$7.75B
| $2.8M | ﹤0.01% |
+10,000
| New | +$2.4M |
|
2542
CALL
MetLife
MET
$62.4B
| $2.8M | ﹤0.01% |
45,400
| – | – |
|
|
SOHU
2543
Sohu.com
SOHU
$352M
| $2.8M | ﹤0.01% |
134,395
+124,293
| +1,230% | +$2.65M |
|
2544
EVgo
EVGO
$219M
| $2.8M | ﹤0.01% |
+343,543
| New | +$3.47M |
|
2545
First Interstate BancSystem
FIBK
$3.67B
| $2.79M | ﹤0.01% |
69,422
+63,691
| +1,111% | +$2.7M |
|
2546
Build-A-Bear
BBW
$445M
| $2.79M | ﹤0.01% |
164,747
+13,628
| +9% | +$223K |
|
2547
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.79M | ﹤0.01% |
36,100
+17,100
| +90% | +$1.35M |
|
2548
Teekay
TK
$996M
| $2.79M | ﹤0.01% |
762,260
-191,467
| -20% | -$603K |
|
|
GRNA
2549
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $2.79M | ﹤0.01% |
282,101
+20,818
| +8% | +$204K |
|
|
LTCH
2550
DELISTED
Latch, Inc. Common Stock
LTCH
| $2.79M | ﹤0.01% |
247,366
+81
| +0% | +$1K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.